Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corp. Plc | 23.83% | 20.94 | 1.7% | $162.94m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.85% | 27.01 | 14.1% | $158.93m | |
| BHC | Bausch Health Cos., Inc. | 1.85% | 27.01 | 0.0% | $119.66m | |
| GWPH | GW Pharmaceuticals Plc | -3.38% | 109.40 | 6.2% | $81.05m | |
| MDCO | The Medicines Co. | -3.58% | 53.39 | 20.2% | $78.63m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.11% | 132.33 | 2.3% | $69.12m | |
| SAGE | SAGE Therapeutics, Inc. | -1.93% | 141.55 | 8.6% | $52.41m | |
| PRGO | Perrigo Co. Plc | -1.67% | 48.28 | 6.8% | $46.00m | |
| ENDP | Endo International Plc | 0.61% | 4.14 | 8.8% | $44.46m | |
| HZNP | Horizon Therapeutics Plc | 0.73% | 30.23 | 6.6% | $40.27m | |
| UTHR | United Therapeutics Corp. | -1.53% | 89.57 | 14.3% | $39.81m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.29% | 83.02 | 16.9% | $39.56m | |
| ICLR | ICON plc | 0.73% | 147.24 | 4.1% | $37.50m | |
| CTLT | Catalent, Inc. | -0.74% | 49.48 | 2.4% | $32.17m | |
| AERI | Aerie Pharmaceuticals, Inc. | -0.89% | 18.88 | 6.8% | $26.95m |
Company Profile
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.